InvestorsHub Logo
Followers 3
Posts 277
Boards Moderated 0
Alias Born 12/21/2022

Re: None

Thursday, 06/08/2023 12:37:26 PM

Thursday, June 08, 2023 12:37:26 PM

Post# of 3283
"For example, we’ve considered an alternative pegylated filgrastim (such as Spectrum’s eflapegrastim, marketed under the brand name Rolvedon) as a biobetter of Neulasta (pegfilgrastim)".
https://www.primetherapeutics.com/news/biobetters-wait-what-im-just-figuring-out-biosimilars-part-4/